Vaginal Ewing Sarcoma: An Uncommon Clinical Entity in Pediatric Patients

Por Cross, Nathan M, Stanescu, A Luana, Rudzinski, Erin R, Hawkins, Douglas S, Parisi, Marguerite T
Publicado no J Clin Imaging Sci (2017)

OR27-04 Risk Factors For Low Baseline Bone Mineral Density In Gender Diverse Youth

Por Hodax, Juanita K, Brady, Charles, DiVall, Sara A, Carlin, Kristen, Khalatbari, Hedieh, Parisi, Marguerite T, Salehi, Parisa
Publicado no J Endocr Soc (2020)

Comparison of (123)I-Metaiodobenzylguanidine (MIBG) and (131)I-MIBG Semi-Quantitative Scores in Predicting Survival in Patients With Stage 4 Neuroblastoma: A Report From the Childr...

Por Naranjo, Arlene, Parisi, Marguerite T., Shulkin, Barry L., London, Wendy B., Matthay, Katherine K., Kreissman, Susan G., Yanik, Gregory A.
Publicado no Pediatr Blood Cancer (2011)

Semiquantitative mIBG Scoring as a Prognostic Indicator in Patients with Stage 4 Neuroblastoma: A Report from the Children’s Oncology Group

Por Yanik, Gregory A., Parisi, Marguerite T., Shulkin, Barry L., Naranjo, Arlene, Kreissman, Susan G., London, Wendy B., Villablanca, Judith G., Maris, John M., Park, Julie R., Cohn, Susan L., McGrady, Patrick, Matthay, Katherine K.
Publicado no J Nucl Med (2013)

Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Pediatric Thyroid Cancer

Por Francis, Gary L., Waguespack, Steven G., Bauer, Andrew J., Angelos, Peter, Benvenga, Salvatore, Cerutti, Janete M., Dinauer, Catherine A., Hamilton, Jill, Hay, Ian D., Luster, Markus, Parisi, Marguerite T., Rachmiel, Marianna, Thompson, Geoffrey B., Yamashita, Shunichi
Publicado no Thyroid (2015)

Randomised Phase II Trial of Irinotecan/Temozolomide (I/T) with Temsirolimus (TEM) or Dinutuximab (DIN) in Children with Refractory or Relapsed Neuroblastoma: A Report from The Chi...

Por Mody, Rajen, Naranjo, Arlene, Van Ryn, Collin, Yu, Alice L., London, Wendy B., Shulkin, Barry L., Parisi, Marguerite T., Servaes, Sabah-E-Noor, Diccianni, Mitchell B., Sondel, Paul M., Maris, John M., Park, Julie R., Bagatell, Rochelle
Publicado no Lancet Oncol (2017)

Anti-tumor activity and tolerability of hu14.18-IL2 with GMCSF and isotretinoin in recurrent or refractory neuroblastoma: a Children’s Oncology Group phase II study

Por Shusterman, Suzanne, Naranjo, Arlene, Van Ryn, Collin, Hank, Jaquelyn A., Parisi, Marguerite T., Shulkin, Barry L., Servaes, Sabah, London, Wendy B., Shimada, Hiroyuki, Gan, Jacek, Gillies, Steven D., Maris, John M., Park, Julie R., Sondel, Paul M.
Publicado no Clin Cancer Res (2019)

MIBG avidity correlates with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children’s Oncology Group

Por DuBois, Steven G., Mody, Rajen, Naranjo, Arlene, Van Ryn, Collin, Russ, Douglas, Oldridge, Derek, Kreissman, Susan, Baker, David L., Parisi, Marguerite, Shulkin, Barry L., Bai, Harrison, Diskin, Sharon J., Batra, Vandana, Maris, John M., Park, Julie R., Matthay, Katherine K., Yanik, Gregory
Publicado no Pediatr Blood Cancer (2017)

Phase II study of oral capsular 4-hydroxyphenylretinamide (4-HPR/fenretinide) in pediatric patients with refractory or recurrent neuroblastoma: A report from the Children’s Oncolog...

Por Villablanca, Judith G., London, Wendy B., Naranjo, Arlene, McGrady, Patrick, Ames, Matthew M., Reid, Joel M., McGovern, Renee M., Buhrow, Sarah A., Jackson, Hollie, Stranzinger, Enno, Kitchen, Brenda J., Sondel, Paul M., Parisi, Marguerite T., Shulkin, Barry, Yanik, Gregory A., Cohn, Susan L., Reynolds, C. Patrick
Publicado em 2011

Validation of Postinduction Curie Scores in High-Risk Neuroblastoma: A Children’s Oncology Group and SIOPEN Group Report on SIOPEN/HR-NBL1

Por Yanik, Gregory A., Parisi, Marguerite T., Naranjo, Arlene, Nadel, Helen, Gelfand, Michael J., Park, Julie R., Ladenstein, Ruth L., Poetschger, Ulrike, Boubaker, Ariane, Valteau-Couanet, Dominique, Lambert, Bieke, Castellani, Maria-Rita, Bar-Sever, Zvi, Oudoux, Aurore, Kaminska, Anna, Kreissman, Susan G., Shulkin, Barry L., Matthay, Katherine K.
Publicado no J Nucl Med (2018)

A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children’s Oncology...

Por Ozkaynak, M. Fevzi, Gilman, Andrew L., London, Wendy B., Naranjo, Arlene, Diccianni, Mitchell B., Tenney, Sheena C., Smith, Malcolm, Messer, Karen S., Seeger, Robert, Reynolds, C. Patrick, Smith, L. Mary, Shulkin, Barry L., Parisi, Marguerite, Maris, John M., Park, Julie R., Sondel, Paul M., Yu, Alice L.
Publicado no Front Immunol (2018)

Corrigendum: A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Childr...

Por Ozkaynak, M. Fevzi, Gilman, Andrew L., London, Wendy B., Naranjo, Arlene, Diccianni, Mitchell B., Tenney, Sheena C., Smith, Malcolm, Messer, Karen S., Seeger, Robert, Reynolds, C. Patrick, Smith, L. Mary, Shulkin, Barry L., Parisi, Marguerite, Maris, John M., Park, Julie R., Sondel, Paul M., Yu, Alice L.
Publicado no Front Immunol (2018)

Validation of the mIBG skeletal SIOPEN scoring method in two independent high-risk neuroblastoma populations: the SIOPEN/HR-NBL1 and COG-A3973 trials

Por Ladenstein, Ruth, Lambert, Bieke, Pötschger, Ulrike, Castellani, Maria-Rita, Lewington, Valerie, Bar-Sever, Zvi, Oudoux, Aurore, Śliwińska, Anna, Taborska, Katerina, Biassoni, Lorenzo, Yanik, Gregory A., Naranjo, Arlene, Parisi, Marguerite T., Shulkin, Barry L., Nadel, Helen, Gelfand, Michael J., Matthay, Katherine K., Park, Julie R., Kreissman, Susan G., Valteau-Couanet, Dominique, Boubaker, Ariane
Publicado no Eur J Nucl Med Mol Imaging (2017)

Irinotecan, Temozolomide, and Dinutuximab With GM-CSF in Children With Refractory or Relapsed Neuroblastoma: A Report From the Children’s Oncology Group

Por Mody, Rajen, Yu, Alice L., Naranjo, Arlene, Zhang, Fan F., London, Wendy B., Shulkin, Barry L., Parisi, Marguerite T., Servaes, Sabah-E-Noor, Diccianni, Mitchell B., Hank, Jacquelyn A., Felder, Mildred, Birstler, Jennifer, Sondel, Paul M., Asgharzadeh, Shahab, Glade-Bender, Julia, Katzenstein, Howard, Maris, John M., Park, Julie R., Bagatell, Rochelle
Publicado no J Clin Oncol (2020)

Metabolic response as assessed by (18)F‐fluorodeoxyglucose positron emission tomography‐computed tomography does not predict outcome in patients with intermediate‐ or high‐risk rha...

Por Harrison, Douglas J., Chi, Yueh‐Yun, Tian, Jing, Hingorani, Pooja, Mascarenhas, Leo, McCowage, Geoffrey B., Weigel, Brenda J., Venkatramani, Rajkumar, Wolden, Suzanne L., Yock, Torunn I., Rodeberg, David A., Hayes‐Jordan, Andrea A., Teot, Lisa A., Spunt, Sheri L., Meyer, William H., Hawkins, Douglas S., Shulkin, Barry L., Parisi, Marguerite T.
Publicado no Cancer Med (2020)

Long-term follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-risk Neuroblastoma: Children’s Oncology Group Study ANBL0032

Por Yu, Alice L., Gilman, Andrew L., Ozkaynak, M. Fevzi, Naranjo, Arlene, Diccianni, Mitchell B., Gan, Jacek, Hank, Jacquelyn A., Batova, Ayse, London, Wendy B., Tenney, Sheena C., Smith, Malcolm, Shulkin, Barry L., Parisi, Marguerite, Matthay, Katherine K., Cohn, Susan L., Maris, John M., Bagatell, Rochelle, Park, Julie R., Sondel, Paul M.
Publicado no Clin Cancer Res (2021)

Role of Extent of Prophylactic Regional Lymph Node Radiotherapy on Survival in High Risk Neuroblastoma: A Report from the COG A3973 Study

Por Braunstein, Steve E., London, Wendy B., Kreissman, Susan G., Villablanca, Judith G., Davidoff, Andrew M., DeSantes, Kenneth, Castleberry, Robert P., Murray, Kevin, Diller, Lisa, Matthay, Katherine, Cohn, Susan L., Shulkin, Barry, von Allmen, Daniel, Parisi, Marguerite T., Van Ryn, C. Collin, Park, Julie R., Quaglia, Michael P. La, Haas-Kogan, Daphne A.
Publicado no Pediatr Blood Cancer (2019)

Pathologic response in children and adults with large unresected intermediate- or high-grade soft tissue sarcoma receiving preoperative chemoradiation with or without pazopanib (AR...

Por Weiss, Aaron R., Chen, Yen-Lin, Scharschmidt, Thomas J., Chi, Yueh-Yun, Tian, Jing, Black, Jennifer O., Davis, Jessica L., Fanburg-Smith, Julie C., Zambrano, Eduardo, Anderson, James, Arens, Robin, Binitie, Odion, Choy, Edwin, Davis, Justin W., Hayes-Jordan, Andrea, Kao, Simon C., Kayton, Mark L., Kessel, Sandy, Lim, Ruth, Meyer, William H., Million, Lynn, Okuno, Scott H., Ostrenga, Andrew, Parisi, Marguerite T., Pryma, Daniel A., Randall, R. Lor, Rosen, Mark A., Schlapkohl, Mary, Shulkin, Barry L., Smith, Ethan A., Sorger, Joel I., Terezakis, Stephanie, Hawkins, Douglas S., Spunt, Sheri L., Wang, Dian
Publicado no Lancet Oncol (2020)